Skip to main content
. 2018 Oct 29;21:1403–1408. doi: 10.1016/j.dib.2018.10.131
Subject area Gastrointestinal inflammation
More specific subject area Colitis, gut inflammation, intestinal microbiome, biological signature
Type of data Figures
How data was acquired LC/TOF-MS and GC/TOF-MS
Data format Analyzed
Experimental factors Ginsenoside compound K was determined in mouse fecal samples with or without metronidazole treatment. Fecal metabolomic profiles of DSS mice and ginseng treated DSS mice were investigated.
Experimental features Metabolomic fecal profiling from DSS model group and ginseng treated group
Data source location Data was collected at University of Chicago, Chicago, IL, USA
Data accessibility Data is provided within this article
Related research article C.Z. Wang, H. Yao, C.F. Zhang, L. Chen, J.Y. Wan, W.H. Huang, et al., American ginseng microbial metabolites attenuate DSS-induced colitis and abdominal pain, Int. Immunopharmacol. 64 (2018) 246–251.[1](DOI:10.1016/j.intimp.2018.09.005)